Fusaroli M.; Raschi E.; Contin M.; Sambati L.; Menchetti M.; Fioritti A.; Poluzzi E., Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list, «PARKINSONISM & RELATED DISORDERS», 2021, 90, pp. 79 - 83 [articolo]
Gatti, Milo; Raschi, Emanuel; Moretti, Ugo; Ardizzoni, Andrea; Poluzzi, Elisabetta; Diemberger, Igor, Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase, «VACCINES», 2021, 9, Article number: 19, pp. 1 - 13 [articolo]Open Access
Scarpone, M; Bergami, M; Cenko, E; Bugiardini, R; Poluzzi, E; Manfrini, O, Previous psychiatric disorders and antipsychotic drugs in COVID-19 patients: early findings on possible worse outcome, «EUROPEAN HEART JOURNAL», 2021, 42, pp. 2753 - 2753 [abstract]
Aiello V.; Fusaroli M.; Raschi E.; Palazzini M.; Hu L.; Barbuto S.; Poluzzi E.; Capelli I., Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry, «KIDNEY INTERNATIONAL REPORTS», 2021, 6, pp. 2472-2477 - 2477 [articolo]Open Access
Montalti M.; Solda' G.; Di Valerio Z.; Salussolia A.; Lenzi J.; Forcellini M.; Barvas E.; Guttmann S.; Messina R.; Poluzzi E.; Raschi E.; Riccardi R.; Fantini M.P.; La Fauci G.; Gori D., ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance, «ECLINICALMEDICINE», 2021, 38, Article number: 101027, pp. 1 - 7 [articolo]Open Access
Gatti M.; Fusaroli M.; Raschi E.; Moretti U.; Poluzzi E.; De Ponti F., Serious adverse events with tedizolid and linezolid: pharmacovigilance insights through the FDA adverse event reporting system, «EXPERT OPINION ON DRUG SAFETY», 2021, 20, pp. 1421 - 1431 [articolo]
Gatti, M.; Fusaroli, M.; Caraceni, P.; Poluzzi, E.; De Ponti, F.; Raschi, E., Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2021, 87, pp. 1533 - 1540 [articolo]Open Access
Raschi E.; Fadini G.P.; Diemberger I.; Poluzzi E.; De Ponti F., SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?, «EXPERT OPINION ON PHARMACOTHERAPY», 2021, 22, pp. 647 - 650 [articolo]
Dika, Emi; Mastroeni, Simona; Lambertini, Martina; Scarfì, Federica; Patrizi, Annalisa; Veronesi, Giulia; Magnaterra, Elisabetta; Borghi, Alessandro; Corazza, Monica; Diemberger, Igor; Poluzzi, Elisabetta; Fortes, Cristina, The chronic use of multiple photosensitizing drugs is associated with Breslow thickness in female melanoma patients: A bicentric retrospective study, «JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY», 2021, 84, pp. 1762 - 1764 [articolo]
Raschi E.; La Placa M.; Poluzzi E.; De Ponti F., The value of case reports and spontaneous reporting systems for pharmacovigilance and clinical practice, «BRITISH JOURNAL OF DERMATOLOGY», 2021, 184, pp. 581 - 583 [articolo]Open Access
Raschi, Emanuel; Fusaroli, Michele; Ardizzoni, Andrea; Poluzzi, Elisabetta; De Ponti, Fabrizio, Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System, «CANCERS», 2021, 13, Article number: 1758, pp. 1 - 12 [articolo]Open Access
Raschi E.; Caraceni P.; Poluzzi E.; De Ponti F., Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19?, «EXPERT OPINION ON DRUG SAFETY», 2020, 19, pp. 1367 - 1369 [replica/breve intervento]
Capelli, Irene; Vitali, Francesca; Zappulo, Fulvia; Martini, Silvia; Donadei, Chiara; Cappuccilli, Maria; Leonardi, Luca; Girardi, Anna; Aiello, Valeria; Galletti, Silvia; Faldella, Giacomo; Poluzzi, Elisabetta; DE Ponti, Fabrizio; LA MANNA, Gaetano, Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors, «IN VIVO», 2020, 34, pp. 1333 - 1339 [articolo]Open Access
Frega G.; Palloni A.; Di Pasquale G.; Saccoccio G.; Rizzo A.; Poluzzi E.; Iannone P.; Brandi G., Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements, «FRONTIERS IN PHARMACOLOGY», 2020, 11, Article number: 559996, pp. 1 - 6 [articolo]Open Access
Raschi E.; Fusaroli M.; Diemberger I.; Poluzzi E., Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance, «DRUG SAFETY», 2020, 43, pp. 1191 - 1194 [articolo]
